Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Time for shareholder activism?

<< Previous

Bullboard Posts

Next >>

Comment by YegJeeberon Mar 30, 2023 5:21pm

136 Views

Post# 35370439

RE:RE:RE:RE:Time for shareholder activism?

This is a clinical stage biotech development company. You should be investing in Apple, Shell, Proctor and Gamble, or Pfizer. Clearly you don't understand biotech risk. And I'm calling BS on your "holdings" - if you actually had as many as you are saying you do, you would NOT have the need to spew it on here. But nice try....

<< Previous

Bullboard Posts

Next >>

FE Battery Metals begins 2024 winter drill program